Back to News
Market Impact: 0.25
Haemonetics (HAE) Q2 Earnings and Revenues Surpass Estimates
Source: zacks.com
Corporate EarningsAnalyst EstimatesCompany FundamentalsHealthcare & Biotech
Haemonetics reported quarterly earnings of $1.35 per share, beating the Zacks Consensus Estimate of $1.30 by $0.05, or about 3.8%. Earnings were up from $1.27 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
HAE0.45
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook